Small Molecule API CDMOs

Recordati is an Italian pharmaceutical company with both a proprietary product business (rare diseases, specialty/primary care) and a fine chemicals/CDMO division. Recordati Fine Chemicals (also known as Recordati Industria Chimica e Farmaceutica) provides contract API manufacturing. They have FDA-registered facilities, 26 approved products across multiple dosage forms, and significant industrial operations. The fine chemicals division offers API development and manufacturing services to third-party pharmaceutical companies.

Regis Custom Pharma (Regis Technologies, Inc.)

United States

Regis Technologies (now part of ESTEVE CDMO/Esteve Quimica) is a US-based API CDMO specializing in small molecule custom API synthesis, process development, analytical development, and cGMP manufacturing. They combine expertise in organic synthesis with chromatography separations (including chiral separations) to provide customized solutions from discovery to commercial delivery. They also manufacture chromatography products. FDA-registered for API manufacture with clean inspection history.

Reliance Life Sciences (RLS), part of Reliance Industries, is a premier Indian biotechnology company providing contract manufacturing and development services across pharmaceuticals and biosimilars. They have FDA-registered manufacturing facilities with 7 FDA-approved products (injectables, powders, tablets). Their capabilities span API manufacturing, formulation development, biologics/biosimilar manufacturing, and cell and gene therapy R&D. They are a vertically integrated biotech company with 1,000-5,000 employees, offering CDMO services alongside their own product portfolio.

SB-PEPTIDE

France

SB-PEPTIDE (formerly Smart-Bioscience) is a French company specializing in custom peptide synthesis with over 10 years of industrial experience. The company provides peptide synthesis services to pharmaceutical, biotech, and research laboratories worldwide, including custom peptides, PNA synthesis, peptide libraries, process development, and analytical services. All synthesis is performed in France.

Scale Up Laboratory s.r.o.

Czechia

Scale Up Laboratory s.r.o. is a small, privately owned CDMO based in the Czech Republic, operating since 2019. The company provides contract development and manufacturing of APIs and advanced intermediates, including clenbuterol hydrochloride, fluorinated pyrrolidines, and other specialty small molecules. The production facility is located in the Krkonose Mountains area at Mostek.

SCHIRM

Germany

Schirm GmbH is a German contract manufacturing partner for the chemical industry, offering toll manufacturing services in synthesis, formulation, and packaging (Konfektionierung) of agro, fine, and specialty chemicals including pharmaceutical chemicals. The company operates facilities in Germany and the USA, providing production services 365 days a year.

SEDICO Pharmaceutical Company is an Egypt-based pharmaceutical manufacturer and API producer, providing contract manufacturing (CMO/CDMO) services. The company manufactures a broad range of pharmaceutical products including oral solids, injectables, and various dosage forms. SEDICO has recently entered oncology drug production through a partnership with Sandoz Global to localize oncology pharmaceutical products in Egypt.

Shanghai Haoyuan Chemexpress Co., Ltd.

China

Shanghai Haoyuan ChemExpress Co., Ltd. (688131.SS) is a China-based integrated CRO/CDMO founded in 2006, specializing in small molecule and new modalities CDMO services for pharmaceutical and biotech companies. Listed on the Shanghai Stock Exchange, ChemExpress provides services spanning drug discovery CRO through commercial-scale CDMO, with recent expansion into ADC manufacturing via a new GMP production site.

Smilax Laboratories Limited

India

Smilax Laboratories Limited is a research-driven, vertically integrated Indian pharmaceutical company specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates for the generics market. The company operates multiple manufacturing units including facilities in J.N. Pharma City, Anakapalli District.

SONEAS

Hungary

SONEAS Chemicals Ltd is a European CRO/CDMO based in Budapest, Hungary, now part of the UQUIFA group. With over 25 years of experience, the company supports customers from preclinical through Phase 1-3 clinical trials with kilo lab, pilot plant, and large-scale cGMP manufacturing of APIs and key starting materials (KSMs). SONEAS brings over 180KL of KSM cGMP capacity to the UQUIFA portfolio.

DUPLICATE ENTRY: This is the same company as Sri Krishna Pharmaceuticals Ltd (companyId: 12028a28). SKPL was established in 1974 and specializes in bulk manufacture of APIs, DC granules, and finished dosage forms. See primary entry for full profile.

DUPLICATE ENTRY: This is the same company as Sri Krishna Pharmaceuticals Ltd (companyId: 12028a28). SKPL was established in 1974 and specializes in bulk manufacture of APIs, DC granules, and finished dosage forms. See primary entry for full profile.

DUPLICATE ENTRY: This is the same company as Standard Chem. & Pharm. Co. Ltd (companyId: 6a650983). See primary entry for full profile. Standard Chem. & Pharm. Co., Ltd. (SCP) is a Taiwanese CDMO established in 1967.

STA Pharmaceutical Co., Ltd. (WuXi STA) is a subsidiary of WuXi AppTec and one of the world's leading CDMOs, specializing in integrated CMC services for small molecule APIs and drug products (oral and injectable/sterile) from preclinical to commercial scale. They also have capabilities in oligonucleotides, peptides, and bioconjugates. WuXi STA operates 9-14 global manufacturing sites across Asia, North America, and Europe with uniform quality/EHS standards approved by major regulators. They have supported 50+ first-time drug approvals since 2017 across 105 countries. The company has 5,100+ scientists, claims 100% PPQ success rate, and serves 1,200+ customers. Their Changzhou site has passed US FDA inspection and they have a continuous manufacturing line for oral solid dose.

Sterling Italy (Sterling S.p.A.) is a long-established Italian manufacturer specializing in the development, optimization, and manufacturing of steroidal APIs including corticosteroids, hormones, anabolics, estrogens, and progestinics. The company operates GMP production plants in Perugia, Italy and exports APIs to over five continents.

ST Pharm is a South Korean global API CDMO company founded in 1983, specializing in small molecule APIs, oligonucleotide therapeutics (ASO, siRNA, aptamers), and mRNA-LNP manufacturing. The company operates cGMP manufacturing facilities in South Korea and has a CRO subsidiary (AnaPath) in Switzerland and Spain for preclinical pathology services.

Sunny Pharmtech Inc. is a Taiwan-headquartered integrated specialty pharmaceutical CDMO specializing in high-potency APIs and drugs, including small molecules, peptides, and ADC linker-payloads. The company develops complex, high-barrier, niche drugs including ANDAs and 505(b)(2) filings, with state-of-the-art facilities offering OEB 5 containment and capabilities from early-stage formulation development to commercial manufacturing.

Symbiotec Pharmalab is a leading Indian manufacturer of corticosteroid and steroidal-hormone APIs with a global leadership position. With over 30 years of experience, the company has evolved from lab-scale manufacturing to industrial-scale production, operating two FDA-approved facilities (Rau and Pithampur, Indore). The company offers integrated CDMO solutions across organic chemistry, biotechnology/fermentation, and complex injectable platforms. It holds a 50%+ global market share in key steroid API molecules and serves 200+ customers in 40+ countries.

SyntalPharma (Syntal Pharma Sp. z o.o.)

Poland

SyntalPharma is a Polish/Swiss venture established in 2015, operating as a custom synthesis and contract manufacturing organization for API intermediates and active pharmaceutical ingredients. The company has a dedicated 85 sq. m. Class D cleanroom facility with an associated analytical laboratory. SyntalPharma offers custom synthesis with full GMP documentation, multi-step synthesis, upscaling from mg to many kg, synthesis of carbohydrates, imidazoles, chiral compounds, heterocyclics, and long-chain compounds.

Synthesia a.s.

Czechia

Synthesia a.s. is a major Czech chemical manufacturer with over 100 years of history, headquartered in Pardubice. The Organics division produces pharmaceutical intermediates and APIs including Vitamin D derivatives. Key chemical technologies include nitration, hydrogenation, and phosgenation. FDA-registered with FEI number, with 5 FDA inspections (all VAI). The company supplies APIs and intermediates to the global pharmaceutical industry but positions itself primarily as a chemical/API manufacturer rather than a full-service CDMO.

Takasago International Corp

Japan

Takasago International Corporation is a Japanese company founded in 1920, primarily known as a global flavors and fragrances company. Their Fine Chemical Division operates as a CDMO specializing in the development and manufacturing of high-value API intermediates and pharmaceutical fine chemicals. They are known for their proprietary chiral catalysis technology (asymmetric synthesis) and continuous flow chemistry capabilities. The company has an FDA-registered manufacturing site (2 inspections, both VAI) and holds DMFs. The Fine Chemical/CDMO business is a distinct division within the larger flavors/fragrances company.

TBD Pharmatech

Estonia

TBD Pharmatech (formerly TBD-Biodiscovery) is an EU-based small-molecule API CDMO headquartered in Tartu, Estonia. They are a dual-site, EU-GMP-certified organization specializing in small-molecule API development and niche-to-mid-volume commercial manufacturing. Services include end-to-end CDMO (route scouting to commercial supply), technology transfer, clinical and commercial batch production under cGMP, analytical method development, QP (Qualified Person) release, CMC regulatory support, and API distribution/sourcing under GDP. EU-GMP certified since 2008, ISO 9001 certified, FDA-registered for API manufacture and analysis. They operate two GMP facilities (Tiigi and Valja sites) in Tartu.

Chinese pharmaceutical manufacturer specializing in corticosteroid, hormone, and steroid API production. Subsidiary of Shanghai Pharmaceuticals (Shanghai Xinyi Pharmaceutical Factory). Founded in 1992, located in Tianjin with approximately 170,000 sq meters across two factory areas and 507 employees. Main products include hydrocortisone, spironolactone, hydrocortisone acetate, clobetasol propionate, and related corticosteroid APIs. Also produces tablet formulations (9 approved products). Has 11 API production licenses and 9 tablet production licenses. FDA-registered with 3 FEI numbers, 13 inspections (4 NAI, 8 VAI, 1 OAI), and 2 FDA-approved finished dosage form products.

TopChem Pharmaceuticals

Ireland

TopChem Pharmaceuticals Limited is an Irish GMP manufacturer of niche, low-volume active pharmaceutical ingredients (APIs), excipients, and other cGMP materials for the global generic and specialty pharmaceutical sector. Established in 2006, the company targets difficult-to-source products where volumes are low or special high grades are required. TopChem holds EU cGMP certification and has been FDA-inspected, operating from sites in Ballymote and Collooney, County Sligo, Ireland.

Valsynthèse SA (Valsynthese)

Switzerland

Valsynthese SA, part of SSE Group, is a Swiss custom synthesis and contract manufacturing company based in Brig, Switzerland. The company has been operating for 40+ years and specializes in high-energetic and highly hazardous chemistry. Their manufacturing facilities are both ISO and cGMP certified and produce advanced intermediates for fine chemicals and pharmaceutical products, as well as Active Pharmaceutical Ingredients with DMF registration. They hold ISO 9001, ISO 14001, and ISO 45001 certifications along with GMP and FAMI-QS certifications. Core competencies include hazardous chemical synthesis and large-scale Grignard reagent production via flow process (in collaboration with Chemium).

Vijayasri Organics Private Limited

India

Vijayasri Organics Private Limited is an India-based pharmaceutical API manufacturer with FDA registration (FEI numbers 3008408466 and 3009451765). The company has manufacturing facilities and supplies APIs globally. FDA inspection history shows 3 inspections (1 NAI, 2 VAI, latest June 2024), indicating active regulatory compliance. No website content available (site appears to be down), but search results and FDA records confirm API manufacturing operations from Visakhapatnam, India.

WeylChem

Germany

WeylChem is the fine and specialty chemicals platform of International Chemicals Investors Group, operating as a CDMO for custom manufacturing of fine chemicals and pharmaceutical intermediates. With nine companies and around 1,400 employees across seven manufacturing sites in Europe, North America, and Asia, WeylChem provides custom synthesis from pilot scale through to large-scale commercial production in vessels up to 20 cubic meters.

Yuhan CDMO (Yuhan Chemical)

South Korea

Yuhan Chemical Inc. is a South Korean company and the API CDMO arm of Yuhan Corporation, focused on custom development and manufacturing of active pharmaceutical ingredients, intermediates, and regulated starting materials. Founded in 1980, it operates the largest API production capacity in Korea (~500,000L reactor volume) across Ansan and Hwaseong plants.

Yuki Gosei Kogyo Co., Ltd.

Japan

Yuki Gosei Kogyo Co., Ltd. is a Japanese fine chemical manufacturer providing GMP-compliant contract manufacturing of pharmaceutical intermediates, new drugs, and generics. The company has extensive experience in drug development, manufacturing, and commercialization, exporting to more than 30 countries worldwide.

Zambon is an Italian multinational healthcare group founded in 1906 with EUR 899 million in revenues and 2,768 employees. The group operates as both a pharmaceutical company (Zambon Pharma) and a CDMO, offering contract development and manufacturing services ranging from development through commercial production. Manufacturing plants in Vicenza (Italy), Cadempino (Switzerland), Haikou (China), and Barueri (Brazil) supply 87 countries. Also includes Zach System (API custom synthesis) as its chemical division.

Zhejiang Davi Pharmaceutical Co., Ltd., established in 2004, is an exclusively foreign-owned high-tech manufacturer of active pharmaceutical ingredients and intermediates located in Huzhou City, Zhejiang, China. With a total investment of $8M USD and 35,000 m2 floor space, they operate FDA and COS-required GMP workshops. They specialize in folate-related APIs: Methotrexate, Methotrexate Sodium, Calcium Folinate (Leucovorin Calcium), Calcium Levofolinate, and L-5-Methyltetrahydrofolate Calcium. The company is FDA-registered with 3 FEI numbers, has 8 FDA inspections (2 NAI, 6 VAI, 0 OAI), 1 Class II recall, 4 FDA-approved products (tablet, extended-release tablet), and participates at CPHI events globally. They undertake OEM orders for intermediates. Classified as API manufacturer rather than CDMO because they primarily manufacture their own specialty APIs; contract services appear limited to OEM intermediate orders.

Zhejiang Hisoar Pharmaceutical Co., Ltd. (stock code 002099, Shenzhen Exchange), founded in 1966 and headquartered in Taizhou, Zhejiang, China, is a diversified pharmaceutical and chemical company with ~3,000 employees and 426 R&D personnel. Their pharmaceutical division produces specialty APIs, intermediates, formulations, and fine chemicals -- specifically antibiotics (penem/carbapenem series, clindamycin series), cardiovascular agents, and anti-diabetic APIs. Over 70% of products are exported. They also have a major dye/pigment business segment (~70% global market share in Reactive Blue KN-R). The company has 3 FDA-registered FEI numbers for API manufacture, 7 FDA inspections (4 NAI, 3 VAI, 0 OAI), 2 FDA-approved products (capsule, tablet), 40+ invention patents, and partnerships with Boehringer Ingelheim, Merck, Sanofi, Novartis, GSK, and others. Classified as API manufacturer because the core pharma business is own-brand API and intermediate production with limited CDMO positioning, though PharmaSource lists them under CMO/CDMO.

Acebright Group (Shanghai Acebright Pharmaceuticals) is a Chinese pharmaceutical company providing CDMO services through NMPA, FDA, EMA, and WHO-approved sites. They specialize in API manufacturing with over 20 years of technology development, and have a joint venture with Cipla for respiratory products in China.

Aurisco Pharmaceutical Co., Ltd. is a CRDMO (contract research, development and manufacturing organization) headquartered in Taizhou, Zhejiang, China, specializing in generic and complex APIs and finished dosage forms. The company focuses on small-molecule drugs, peptide therapeutics, and oligonucleotide pharmaceuticals. Aurisco operates 4 manufacturing sites and 5 R&D centers in China with 1,500+ staff, has passed 5 cGMP inspections in 2023 (USFDA, EUGMP, PMDA, NMPA, KFDA), and is expanding peptide manufacturing capacity. Their steroid product portfolio includes abiraterone acetate and complex hormone formulations.

Cayman Pharma s.r.o. is a Czech pharmaceutical manufacturer specializing in cGMP prostaglandin Active Pharmaceutical Ingredients (APIs) for ophthalmology and vascular applications. The company owns a patented route to the prostaglandin core structure developed at its headquarters near Prague, and produces APIs including Latanoprost, Travoprost, Bimatoprost, Tafluprost, and Epoprostenol. cGMP compliance is continuously verified by Czech NCAs (SUKL, USKVBL) and the US FDA.

Chemport Inc. is a South Korean pharmaceutical company founded in 2008 that manufactures APIs, particularly EPA ethyl ester (Icosapent Ethyl) used in cardiovascular drugs like Vascepa. The company holds US cGMP and Korean GMP certifications for API manufacturing, with FDA registration and a clean inspection record of 3 NAI outcomes.

Chongqing Carelife Pharmaceutical Co., Ltd. (Kailin Pharmaceutical) is a Chinese pharmaceutical company offering CDMO services for API manufacturing. The company has 2 FDA-registered facilities with 10 FDA inspections on record, producing APIs including clindamycin and amenamevir for domestic and international markets.

Chongqing Huapont Shengchem Pharmaceutical Co., Ltd., founded in 1994, is a subsidiary of listed company Huapont Life Sciences. The company provides integrated R&D, production, and CDMO services for APIs and intermediates with 30+ years of experience, 700m3 reaction volume, 100+ R&D products, and registrations across US, EU, Japan, Korea, and China.

Chongqing Sintaho Pharmaceutical Co., Ltd. is a CDMO with 1 FDA-registered factory and 2 R&D centers, specializing in high-potency small molecules and XDC (antibody-drug conjugate linker-payloads). The company provides drug substance CDMO/CRO services with expertise in API and XDC development showcased at major industry events.

Destilaciones Bordas Chinchurreta S.A. (Bordas)

Spain

Destilaciones Bordas Chinchurreta S.A. is a Spanish company manufacturing active pharmaceutical ingredients (APIs) including diosmin and terpine hydrate under GMP certification. They also produce food-grade and feed-grade ingredients with FSSC 22000, IFS, FAMI-QS, Kosher, and Halal certifications, and hold FDA registration and European CEP certification for their APIs.

D. H. Organics

India

D.H. Organics is an Indian manufacturer and exporter of veterinary APIs and pharmaceutical intermediates with over 40 years of experience. Their product range includes Rafoxanide, Closantel, Closantel Sodium, Nitroxynil, and pharmaceutical intermediates such as 3,5-Diiodosalicylic Acid. They operate an FDA-approved manufacturing facility and supply to more than 30 countries.

DNS Fine Chemicals & Lab. Pvt. Ltd.

India

DNS Fine Chemicals is an Indian manufacturer and supplier of specialty chemicals, Active Pharmaceutical Ingredients, pharmaceutical intermediates, and food processing chemicals. Based in Mumbai with an FDA-certified, ISO 9001, GMP, Kosher, Halal, and FAMI-QS certified facility, they produce chemicals including sodium metaperiodate, periodic acid, and products for pharmaceutical, animal feed, food processing, and personal care industries.

Dottikon Exclusive Synthesis AG

Switzerland

Dottikon Exclusive Synthesis AG is a Swiss CDMO that manufactures high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs) for the global chemical, biotech, and pharmaceutical industry. The company has over 110 years of experience in hazardous chemical reactions and operates an FDA and Swissmedic approved cGMP manufacturing site.

EOS Med Chem Co., Ltd.

China

EOS Med Chem is a Shandong-based Chinese CMO company specializing in GMP custom synthesis of pharmaceutical intermediates and APIs, with more than 100 scientists. The company operates a 75,000 m2 GMP production facility in Shanghe and has passed site audits from major pharma companies including Teva, Hikma, Lonza, Cipla, and Sun Pharma.

Ercros (Pharmaceuticals Division)

Spain

Ercros Pharmaceuticals Division is a Spanish manufacturer of generic active pharmaceutical ingredients, primarily antibiotics produced through fermentation (erythromycin, azithromycin, clarithromycin, fosfomycin, fusidic acid) as well as anti-hypertensives and anti-ulcer drugs by chemical synthesis. The division exports over 90% of its production to approximately 50 countries and also offers custom manufacturing of APIs and intermediates for third parties.

Erregierre SpA

Italy

Erregierre SpA is an Italian API manufacturer founded in 1974, specializing in medium-volume small molecule active pharmaceutical ingredients for human and veterinary use. Located near Bergamo in Northern Italy, the company operates 55 glass-lined and stainless-steel reactors (70 to 10,000 liters) and provides DMF and dossier submission support for highly regulated markets including the US, Japan, South Korea, and Europe.

ESIM Chemicals

Austria

ESIM Chemicals is an Austrian custom manufacturing company with over 80 years of experience in the fine chemicals industry, focusing on the exclusive production of high-quality intermediates and active ingredients for pharmaceutical partners. The company provides custom synthesis from product launch and upscaling through commercial large-scale production, though it filed for bankruptcy proceedings in mid-October (date unspecified) at the Linz Regional Court.

Eskay Iodine Pvt Ltd

India

Eskay Iodine Pvt Ltd is an Indian API manufacturer registered with the FDA (FEI 3010331979) for API manufacturing. The company is part of the S Kant Healthcare group and has received clean FDA inspection results with 2 NAI outcomes.